INKT (STOCKS)
MiNK Therapeutics, Inc. Common Stock
$11.050000
-0.140000 (-1.25%)
Prev close: $11.190000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jennifer S. Buell
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $52.96M
- Employees
- 23
- P/E (TTM)
- -3.64
- P/B (TTM)
- -3.76
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.65 | $-0.87 | +0.2221 | +25.47% |
|
Jun 2025 (Q2)
|
$-1.06 | $-0.56 | -0.5024 | -90.10% |
|
Mar 2025 (Q1)
|
$-0.70 | $-0.62 | -0.0778 | -12.50% |
|
Dec 2024 (Q4)
|
$-0.62 | $-0.51 | -0.1100 | -21.57% |